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MinireviewThe Challenges of Translating Knockout
Phenotypes into Gene Function
beginning at E10.5 and persisting for variable periods,
but no viable offspring were obtained in any of the stud-
ies. At E10.5, the embryos appear normal. With time
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however, the embryos become pale and anemic, haveSt. Jude Children's Research Hospital
variable deficiencies in vascularization of the embryoMemphis, Tennessee 38105
and yolk sac, and show varying degrees of growth retar-
dation. The challenge became to identify the defects
that are directly due to loss of p38a function and to
One of the most significant advances in the study of distinguish these from secondary defects associated
mammalian genes has been the development of ap- with the loss of viability.
proaches to obtain defined mutations in mice. With re- The first article (Allen et al., 2000) noted the embryonic
wards come challenges. Often the deletion of a gene lethality without describing a phenotype. Using p38a
that has accepted functions from biochemical and cell null cells it was demonstrated that MAPKAP-2 is not
biological experiments results in an ªinconsistentº phe- activated in response to anisomycin or arsenite, sup-
notype. Frequently this takes the form of no or mild porting the role of p38a as an upstream activator. IL-1-
phenotypes and evokes the response that a redundantly induced production of IL-6 was greatly reduced through
functioning gene exists. Equally frequently there is a a mechanism affecting mRNA levels. This response is
dramatic phenotype that challenges the investigators' likely to require MAPKAP-2 since LPS-induced IL-6
skills to translate it into gene function and draws them mRNA levels are greatly reduced in MAPKAP-2-deficient
into unknown realms. Efforts to define the functions of spleen cells (Kotlyarov et al., 1999). Lastly, LPS induction
p38a from the phenotype of null mutants nicely illustrate of TNF-a and IFN-g is deficient in MAPKAP-2 null cells
the complexities. through a mechanism involving altered protein synthe-P38a: A Mitogen-Activated Protein Kinase
sis. Thus, a p38a/MAPKAP-2 pathway is involved in theP38a is a member of the mitogen-activated protein
production of these cytokines. However, the deletion(MAP) kinase family, which contains three subfamilies:
of these cytokine genes does not result in embyronicthe ERKs, the JNKs, and p38 (reviewed in Ono and Han,
lethality and Mapkap2 null mice are viable, therefore2000). The MAP kinases are unique in being activated
these pathways do not explain the embryonic lethality.by tyrosine and threonine phosphorylation. The p38
The role of MKK3 in activating p38a has been con-subfamily contains four members p38a, p38b, p38g,
firmed through the derivation of MKK3-deficient miceand p38d. P38a was cloned as a 38 kDa protein that is
(Lu et al., 1999). Macrophages from these mice haverapidly tyrosine phosphorylated in LPS-stimulated mac-
significantly reduced activation of p38a by LPS. How-rophages or as the target of an anti-inflammatory drug.
ever secretion of TNF-a and IL-6 was normal, which isP38a transmits upstream signals to cellular responses
difficult to reconcile with the observed requirement forthrough the phosphorylation of substrates (reviewed in
p38a in IL-1-induced IL-6 production. Surprisingly, tran-Ichijo, 1999). Activation is mediated by the MAP kinase
scription of the p40 subunit of IL-12 was dramaticallykinases MKK3, MKK6, and possibly MKK4. Each MKK
reduced. An important question is whether LPS-inducedactivates a different spectrum of the p38 subfamily
IL-12 transcription is also affected in p38a- or MAPKAP-members. The MKKs, in turn, are activated by a variety
2-deficient macrophages. Nevertheless, since MKK3-of kinases. The substrates of p38a are numerous and
and IL-12-deficient mice are viable, these studies alsoinclude kinases, transcription factors, and proteins of
provide no clues for the embryonic lethality.undefined functions.
Placental Insufficiency in p38a NullInitial studies of p38a function focused on inflamma-
Embryonic Developmenttory responses and support its role in inflammation by
In two studies of p38a null embryos, detailed analysisregulating cytokine and chemokine production. Subse-
implicated placental insufficency as the probable basisquent studies have shown its activation in the response
for lethality (Adams et al., 2000; Mudgett et al., 2000).to a wide variety of cytokines, growth factors, stress
Although analysis of mutants generally focuses on theenvironments, peptides and cell adhesion processes,
embryo, it is becoming increasingly clear that manyamong others. The proposed physiological roles for
genes affect placental development or function and theirp38a are numerous (reviewed in Nebreda and Porras,
deletion causes embryonic lethalities. Importantly, the2000) and include promoting differentiation of various
associated insufficiencies in nutrient and waste ex-cell types including adiopocytes, myoblasts, neuronal
change cause secondary embryonic phenotypes not di-cells, chrondrocytes, and erythroid cells; roles in pro-
rectly linked to the gene of interest.moting and inhibiting cell proliferation, depending on
During early embryonic development, the outermostcell type and in both inducing and inhibiting cell survival
cells of the morula commit to the trophoblast lineage,depending upon cell type. However, these are predicted
a uniquely mammalian cell lineage. The trophoblast lin-from cell lines; the use of inhibitors that are not abso-
eage derivatives will provide essential maternal±embryolutely specific; or with constitutive activators and domi-
contacts throughout gestation (reviewed in Cross, 1998).nant negatives that may affect unrelated pathways. Con-
The first function is to mediate implantation and estab-sequently the availability of mice deficient in p38a is an
lish the critical interactions with the uterus. Subse-essential alternative to defining the roles of p38a.
quently, diploid trophoblasts nearest the inner cell massDerivation of p38a Null Mutants by Multiple Groups
proliferate and differentiate to become the ectoplacentalAt least four groups derived p38a null mice. In all cases,
gene deletion resulted in an embryonic lethal phenotype cone that will ultimately give rise to the placental organ.
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More distal trophoblasts differentiate to giant cells. Cells The authors were also confronted with embryonic lethal-
ity but with potentially important differences. In thefrom the inner cell mass commit to the extraembryonic
primitive endoderm lineage, which gives rise to the pari- above cases, either no viable embryos were found past
etal endoderm that underlies the giant cells and the E13.5 or 1/25 at E13.5 (Mudgett et al., 2000). In Tamura
visceral endoderm. The extraembryonic mesoderm, et al. (2000) 3/52 embryos were viable at E13.5 while
generated during gastrulation, gives rise to blood is- 6/31 embryos were reported viable at E16.5. The authors
lands and blood vessels associated with the visceral speculate that p38a null embryos are challenged with
endoderm (the visceral yolk sac). This mesoderm also two hurdles, the placental insufficiency described by
produces the allantois, the precursor of the umbilical the other groups and a later challenge not seen by the
blood vessels. The visceral yolk sac provides the essen- others. Why a fraction of the p38a null embryos did
tial structure for nutrient and waste exchange until not survive longer in the other three studies is unclear.
approximately E10.5 when the placenta takes on this However, there are examples among the mutations as-
function. The mature placenta consists of an outer tro- sociated with placental insufficiency that show partial
phoblast lineage±derived spongiotrophoblast layer. The penetrance and rather striking strain specificities (Table
underlying labyrinthine layer consists of trophoblast- 1). Whether strain variation is involved in the case of
derived cells in which there is extensive intermingling p38a is unclear since in one study (Mudgett et al., 2000)
of maternal and embryonic blood vessels. two different ES cell lines were used and the progeny
Genes essential for each stage, when deleted, result crossed onto 129/SvEv, C57Bl/6, or Balb/c mice with
in embryonic lethality (examples affecting the placental comparable phenotypes.
phase are listed in Table 1). The study of these genes In Tamura et al. (2000), the second lethal wave is also
is facilitated by a clever trick derived from observations dominated by an anemia. In this case, however, it is
of chimeras formed between diploid embryos and em- linked to a severe block in erythroid differentiation based
bryos made tetraploid by electrofusion at the two-cell on the expression of cell lineage markers in fetal liver
stage (Nagy et al., 1990). When tetraploid cells are mixed cells. As embryonic stem cells are capable of commit-
with either ES cells or diploid embryo cells, the tetraploid ting to and differentiating along the erythroid lineage in
cells only contribute to the primitive endoderm and the both cell culture and in reconstitution experiments, the
trophoblast lineages while the extra-embryonic meso- likely explanation is a lack of erythropoietin (Epo).
derm and the embryo are derived from the ES or diploid The essential role that Epo plays in fetal liver erythro-
embryo cells. Thus, if a defect occurs in the differentia- poiesis is well established. Deletion of the Epo gene,
tion or function of the extraembryonic endoderm or the the receptor for Epo, or the receptor-associated kinase
trophoblast lineage cells, fusion of the mutant embryos Jak2 result in an embryonic lethality by E13. Primitive
or ES cells to wild-type tetraploid cells rescues the de- yolk sac erythropoiesis is not significantly affected but
fect and allows the development of the embryo. This fetal liver definitive erythropoiesis is virtually eliminated.
approach (Table 1) has been used to rescue a number Since these embryonic lethalities occur earlier than
of embyronic lethalities associated with placental defi- E16.5, the absence of p38a must cause a relative reduc-
ciencies and importantly has allowed the identification tion in Epo levels. Irrespective, the important experiment
of embryo phenotypes that arise secondary to defects measures the levels of Epo mRNA in p38a null embryos.
in extraembryonic cells. Using a 50 or 60 cycle PCR approach the authors dem-
The placental defects in p38a null embryos described onstrate a dramatic reduction in fetal liver Epo mRNA
by Mudgett et al. (2000) and Adams et al. (2000) are transcripts. Similarly using a real-time PCR technique
quite similar. Both studies demonstrate that p38a is reductions of at least 10-fold are observed. Other genes
highly expressed in trophoblasts of the labryrinthine layer. such as SCF or thrombopoietin, are less affected.
In both studies the null mutation results in embryonic le-
Epo production and its control by hypoxia have beenthality around E12.5. Embryonic growth retardation after
intensely studied (reviewed in Ebert and Bunn, 1999).E10.5 was noted and ranged from mild on a mixed genetic
Most studies use hepatoma cell lines in which Epobackground to more severe on a C57BL/6 background.
mRNA can be induced 50-fold under hypoxic conditions.Both studies noted a striking reduction in the labyrin-
In addition, the VEGF gene and genes for metabolicthine layer and the lack of intermingling embryonic and
enzymes are regulated through this hypoxic response.maternal blood vessels consistent with a defect in vas-
Although the sensing protein is not known, much iscularization. In one case this was further confirmed by
known about the pathways. Mitochondria are essentialfinding a greatly reduced number of endothelial cells in
for the recognition of hypoxia and respond by the pro-the labryinthine layer. The morphological defects were
duction of reactive oxygen species (ROS) (Chandel etfurther confirmed by the reduced expression of markers
al., 1998). Chemical inducers, such as Cobalt, do notfor diploid trophoblasts and trophoblast giant cells. One
require mitochondria and may activate the pathway bystudy (Mudgett et al., 2000) described a greatly reduced
inducing ROS by other means or by interacting directlyspongiotrophoblast layer while the other study (Adams
with the sensing protein. The consequence is to rescueet al., 2000) reported that it was normal. In Mudgett et
hypoxia-induced factor 1a (HIF-1a) from degradational. (2000), a dramatic reduction of the major blood ves-
mediated by a E3 ubiquitin protein ligase complex con-sels in the yolk sac was described. Lastly, Adams et al.
taining the von Hippel-Lindau tumor suppressor protein(2000) noted a number of embryo phenotypes including
(Maxwell et al., 1999). Saved from degradation, HIF-1aan anemia, reduced embryonic vasculature, including
associates with aryl hydrocarbon nuclear translocatorthe yolk sac, and reduced numbers of cardiomyocytes
(ARNF) to form a heterodimeric complex that initiatesin the heart wall. From the phenotype, the authors con-
transcription from the hypoxia response element. Thecluded that p38a plays an essential role in diploid tro-
essential role of these is demonstrated by an embryonicphoblast differentiation or function.
lethality associated with their deletion. In the case ofAnother Function for p38a
ARNF, lethality is attributed to the loss of induction ofIn this issue of Cell (Tamura et al., 2000), a different
analysis leads to potentially another function for p38a. VEGF resulting in the reduced vascularization of the
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Table 1. Genes Associated with Placental Development
Gene Embryonic Lethality Defects and Comments Referencesa
HGF/c-Met E11.5 Reduced labyrinthine layer. Trophoblasts express c-Met. 3
Allantoic mesenchyme secretes HGF. 22
c-Met deficiency rescued by tetraploid cells.
FGFR2 E10.5 One-third no chorioallanotic fusion, remaining no labryinthine layer. 25
PDGFB Not lethal From E13.5 changes in structure of the labyrinthine layer. 13
PDGFRb
EGFR Variable Midgestation in 129/Sv due to placental defects. 21
Peri-implantation defects in CF-1; viable offspring in CD-1.
VCAM-1 E9.5±11.5 Allantois fails to fuse to chorion. Small number survive and are viable. 5
aV Integrin E10.5 Labyrinthine layer reduced, reduced vascularization. 20% survive. 1
SOS1 E10.5 Labyrinthine layer poorly developed, lacks vascularization. 14
VHL E10.5±12.5 No vascularization of the placenta. 4
UbcM4 E11.5 One third die, remainder born growth retarded. 6
Labyrinthine layer reduced, reduced vascularization.
HSP90b E10.5 Failure to form a labyrinthine layer. 23
RXRa E10 Labyrinthine layer abnormalities. 16
PPARg E9.5 Maturation block of labyrinthine trophoblasts, poor vascularization. 2
Rescued by tetraploid cells.
ARNT E10.5 Vascularization of the labyrinthine layer. 7
Deficiency associated with lack of VEGF. 11
Dlx3 E9.5±10 Altered development of labyrinthine layer. 12
Esxl Not lethal Morphological alterations of the labyrinthine layer. 9
HSF1 E13.5 Highly strain specific, 129/Sv particularly susceptible. 24
Marked reduction in spongiotrophoblast layer.
GCMa E9.5±10 Labyrinthine layer not developed. 18
JunB E10.5 Distribution of giant cells, vascularization of decidua. 17
Failure of labyrinthine layer, vascularization defect.
Rescued with tetraploid cells.
Ets2 E7.5 Small ectoplacental cone, failure of trophoblasts to migrate. 26
No amnion or chorion membranes. Rescued with tetraploid cells.
Mash2 E10 Failure of the spongiotrophoblast layer to develop. 20
Rescued with tetraploid cells.
Hand1 E7.5 Defects in trophoblast giant cells. 15
I-mfa E10.5 Embryonic lethal on C57Bl/6 not on 129/Sv. 8
Reduced numbers of trophoblast giant cells. Interacts with Mash2.
Tfeb E9.5±10.5 Labyrinthine cells fail to express VEGF, vascularization defect. 19
Gata2/Gata3 E9.5±12 Vascularization, controls expression of placental lactogen 1 and 10
proliferin by trophoblasts.
a References: 1Bader, B.L., et al. (1998). Cell 95, 507±519; 2Barak, Y., et al. (1999). Mol. Cell 4, 585±595; 3Dietrich, S., et al. (1999). Development
126, 1621±1629; 4Gnarra, J.R., et al. (1997). Proc. Natl. Acad. Sci. USA 94, 9102±9107; 5Gurtner, G.C., et al. (1995). Genes Dev. 9, 1±14; 6Harbers,
K., et al. (1996). Proc. Natl. Acad. Sci. USA 93, 12412±12417; 7Kozak, K.R., et al. (1997). Dev. Biol. 191, 297±305; 8Kraut, N., et al. (1998). EMBO
J. 17, 6276±6288; 9Li, Y., and Behringer, R.R. (1998). Nat. Genet. 20, 309±311; 10Ma, G.T., et al. (1997). Development 124, 907±914; 11Maltepe,
E., et al. (1997). Nature 386, 403±407; 12Morasso, M.I., et al. (1999). Proc. Natl. Acad. Sci. USA 96, 162±167; 13Ohlsson, R., et al. (1999). Dev.
Biol. 212, 124±136; 14Qian, X., et al. (2000). EMBO J. 19, 642±654; 15Riley, P., et al. (1998). Nat. Genet. 18, 271±275; 16Sapin, V., et al. (1997).
Dev. Biol. 191, 29±41; 17Schorpp-Kistner, M., et al. (1999). EMBO J. 18, 934±948; 18Schreiber, J., et al. (2000). Mol. Cell Biol. 20, 2466±2474;
19Steingrimsson, E., et al. (1998). Development 125, 4607±4616; 20Tanaka, M., et al. (1997). Dev. Biol. 190, 55±65; 21Threadgill, D.W., et al. (1995).
Science 269, 230±234; 22Uehara, Y., et al. (1995). Nature 373, 702±705; 23Voss, A.K., et al. (2000). Development 127, 1±11; 24Xiao, X., et al.
(1999). EMBO J. 18, 5943±5952; 25Xu, X., et al. (1998). Development 125, 753±765; 26Yamamoto, H., et al. (1998). Genes Dev. 12, 1315±1326.
placenta and lack of labyrinthine/spongiotrophoblast factors, HIF-1a may be a target, a possibility excluded
by the authors. In contrast, a role in mRNA stability isformation (Table 1).
The pathways involved in Epo production provide proposed since the SB compound does not affect a
4-fold induction of nuclear run-on activity by CoCl2. RNAample opportunities for modification by p38a and the
concept that a stress kinase is coupled to hypoxia is stability was further explored by inducing Epo mRNA in
Hep3B cells with CoCl2 for 15 hr after which the SBintriguing. The possible validity of the concept is sup-
ported by the observation that hypoxia activates p38a compound was added to a sample of the cells and
mRNA quantitated 3 hr later. A 20%±30% reduction in(Conrad et al., 1999; Tamura et al., 2000). Thus we come
to the second set of experiments reported in the Cell mRNA levels in treated cells, compared to a 10% in-
crease in untreated cells, indicates that p38a is control-article, starting with the observation that inhibitor of
p38a (SB203580) blocks the Epo mRNA appearance fol- ling mRNA turnover. Since small changes in mRNA turn-
over can cause dramatic changes in accumulation, thelowing stimulation of Hep3B cells with CoCl2. Mechanis-
tic insights into this inhibition could be gained by looking authors conclude that this affect accounts for the reduc-
tions seen in fetal livers.at the extent of inhibition of other hypoxia-induced
genes and, in particular, VEGF. No inhibition of VEGF Rescue of Embryonic Lethality with Tetraploid Cells
Thus, we are presented with two very different roles forinduction would suggest that p38a is functioning outside
of the general hypoxic response pathway and would p38a. Are both primary consequences of p38a defi-
ciency? A key observation is provided by Adams eteliminate reduced VEGF as a cause of the vasculariza-
tion defects. Since p38a phosphorylates transcription al. (2000), where it is demonstrated that the embryonic
Cell
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lethality can be rescued by tetraploid cells. The rescue essential for early embryonic vascularization and its de-
ficiency results in a lethal phenotype at E11 (Yang etalso eliminated the embryo±associated phenotypes in-
cluding the anemia, vascularization of the embryo and al., 2000). It will be intriguing to determine whether the
embryonic lethality associated with Mekk3 deficiencythe yolk sac, and the heart defects. Therefore, the rescue
would place the blame for the embryonic lethality on can also be rescued with tetraploid cells.
The immediate activators of p38a in trophoblasts arethe placental defects. However, this presumes that the
fetal liver is the primary site of Epo production. Is it possible not known. The lack of a comparable phenotype in
MKK3-deficient embryos would suggest that this kinasethat extraembryonic tissues produce Epo? One could
then simply propose that Epo provided by the wild-type is not uniquely required for p38a activation. The poten-
tial downstream targets of p38a in trophoblasts are nu-extraembryonic endoderm and/or trophoblasts sustained
development. Both the presence and absence of Epo merous (Table 1). At this point all that can be conclu-
sively deduced is that MAPKAP-2 is not a nonredundantin extraembryonic tissues have been reported (Labastie
et al., 1984; Yasuda et al., 1996). The observation that component of the pathway. In summary the properties
of the p38a-deficient stains of mice present interestingin vivo yolk sac stem cells produce primitive red cells but
when exposed to Epo in tissue culture produce definitive challenges and opportunities for defining the signaling
pathways that require this kinase. With the ability tored cells would argue against the production of Epo in
extraembryonic tissues. However, if the reasoning is rescue embryos with tetraploid cells and reconstitute
adult mice with fetal liver cells, it will be possible tocorrect, tetraploid cells will rescue the embryonic lethal-
ity associated with Epo deficiency. Alternatively, trans- study the role of p38a in a variety of cell lineages. Indeed,
in studies of many signaling pathways, the use of care-genic expression of Epo should rescue the embryonic
lethality attributed to Epo deficiency. fully designed and analyzed mutant mice is filtering the
noise from critical signals in signal transduction.There are two other possibilities that must be consid-
ered. First p38a may contribute to the levels of Epo
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